Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Neuro-immunology
When do you offer high-dose vitamin D for patients with multiple sclerosis with normal serum levels?
In light of publication from
Thouvenot et al in JAMA
Related Questions
Would a longstanding diagnosis of multiple sclerosis impact your radiation recommendations for a patient with breast cancer?
For patients on anti-CD20 therapy for MS without frequent/opportunistic infections, are there serum IgG levels or ALC levels in which you pause or change therapy due to low levels?
What are potential pitfalls in the use of OCT to support a diagnosis of multiple sclerosis?
What biomarkers best predict the response to B-cell depleting therapies in MS?
How would you approach the decision to escalate DMT in a patient with relapsing multiple sclerosis who has two to three new T2 lesion but no clinical symptoms?
How do you decide on long term immunosuppression therapy for Susac Syndrome?
Can you use a JAK inhibitor and Mavenclad in a patient with both multiple sclerosis and rheumatoid arthritis?
What criteria do you use to differentiate between MOGAD and MS in pediatric patients?
What is the diagnostic approach and management for suspected Hashimoto Encephalitis?
What is the role of skin biopsy for evaluating small fiber neuropathy in patients with rheumatic disease who have treatment recalcitrant pain?